1
Clinical Trials associated with PD-1 Knockout Targeting MUC1 CAR-T Cells(Guangzhou Anjie Biomedical Technology)Exploratory Clinical Study of PD-1 Knockout Targeting MUC1 CAR-T Cells (AJMUC1) in the Treatment of MUC1-positive Advanced Breast Cancer
This exploratory clinical study aims to assess the safety and preliminary efficacy of an immunotherapy using PD-1 knockout anti-MUC1 CAR-T cells in the treatment of advanced MUC1-positive breast cancer
100 Clinical Results associated with PD-1 Knockout Targeting MUC1 CAR-T Cells(Guangzhou Anjie Biomedical Technology)
100 Translational Medicine associated with PD-1 Knockout Targeting MUC1 CAR-T Cells(Guangzhou Anjie Biomedical Technology)
100 Patents (Medical) associated with PD-1 Knockout Targeting MUC1 CAR-T Cells(Guangzhou Anjie Biomedical Technology)
100 Deals associated with PD-1 Knockout Targeting MUC1 CAR-T Cells(Guangzhou Anjie Biomedical Technology)